z-logo
open-access-imgOpen Access
High cost of new drugs
Author(s) -
Mariana Mazzucato
Publication year - 2016
Publication title -
bmj
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.831
H-Index - 429
ISSN - 1756-1833
DOI - 10.1136/bmj.i4136
Subject(s) - sofosbuvir , drug pricing , drug prices , negotiation , investment (military) , government (linguistics) , business , access to medicines , public relations , medicine , public economics , economics , actuarial science , political science , intellectual property , chronic hepatitis , law , virology , linguistics , virus , philosophy , ribavirin , politics
Why government must negotiate a better deal for publicly funded research

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom